CAAS Capital Management’s Prelude Therapeutics PRLD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-50,000	Closed	-$3.58M	–	948
2020 Q4	$3.58M	Hold	50,000	–	–	0.03%	156
2020 Q3	$1.51M	Buy	+50,000	New	+$1.51M	0.04%	155